Bellicum Pharmaceuticals, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2014 | $94 M | No. 3 | $50 to $250 million | equity, options | SEC | |
| Nov 2011 | $20 M | No. 2 | $10 to $50 million | equity | SEC | |
| Sep 2010 | $1 M | No. 1 | Under $2 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Bellicum Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2014).
SEC Form D · Sep 2014
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Sep 2014
That is all the official record says: Bellicum Pharmaceuticals, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
7 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC | Fund or asset manager | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Baker Bros. Advisors LP | Fund or asset manager | not stated | not stated | Held preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| David M. Spencer | Person | not stated | not stated | Held Series C preferred stock (Form 3, 2014) | SEC Form 3 |
| Kevin M. Slawin | Person | not stated | not stated | Held Series C preferred stock, director (Form 3, 2014) | SEC Form 3 |
| McGuyer Investments Ltd. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Remeditex Ventures LLC | Venture capital | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Thomas J. Farrell | Person | not stated | not stated | Held Series B and C preferred stock, director (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 76 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Annemarie K. Moseley | Executive officer | Sep 2014 |
| David M. Spencer | Executive officer | Sep 2014 |
| Ken K. Moseley | Executive officer | Sep 2014 |
| Thomas J. Farrell | Executive officer | Sep 2014 |
| Joseph K. Senesac | Executive officer | Oct 2013 |
| Kevin M. Slawin | Executive officer | Oct 2013 |
| David Spencer | Executive officer | Oct 2010 |
| Kevin Slawin | Executive officer | Oct 2010 |
| Thomas Farrell | Executive officer | Oct 2010 |
| Dennis K. Stone | Director | Sep 2014 |
| Frank M. McGuyer | Director | Sep 2014 |
| James F. Brown | Director | Sep 2014 |
| Kevin M. Slawin | Director | Sep 2014 |
| Thomas J. Farrell | Director | Sep 2014 |
| Frank McGuyer | Director | Oct 2010 |
| Kevin Slawin | Director | Oct 2010 |
| Thomas Farrell | Director | Oct 2010 |